A comparison of UW with Eurocollins preservation solution in liver transplantation

J. B. Cofer, G. B. Klintmalm, T. K. Howard, C. V. Morris, B. S. Husberg, R. M. Goldstein, T. A. Gonwa

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Fifty consecutive liver transplants were performed using livers perfused with and stored in University of Wisconsin preservation solution. These grafts were compared with the preceding 55 consecutive transplants performed using livers perfused and preserved with Eurocollins solution. The purpose of the study was to determine if organs preserved with UW solution functioned better after transplantation than organs preserved with Eurocollins. Extensive retrospective analysis of prospectively accumulated data included enzyme levels through 30 days, cost and length of hospital stay, blood product usage, and ischemia time. Average age of patients in the UW group was 47.1 years compared with 39.6 years in the EC group (P < 0.05); cold ischemia time was 7.21 hr in the UW group compared with 5.21 in EC (P = 0.0001). Total bilirubin values were significantly lower on days 0-6 and day 14, but not on day 30, in the UW group. Aspartate aminotransferase was significantly lower in the UW group on days 0-1, 3-6, and 14, but not on day 3 or day 30. Prothrombin times were significantly lower in the UW group across all times (day 0-6, 14, and 30). Intraoperative and postoperative use of packed red blood cells and fresh frozen plasma was lower in the UW group (P ≤ .05). Also, total hospital days, intensive care unit days, and hospital cost to the patient were lower in the UW group (P ≤ .05). A second analysis was done comparing only nonemergent transplants from both groups. These results confirmed the initial analysis of a longer cold ischemia time in the UW group, (P < 0.001), and improved enzyme values in the TBR, AST, and PT in the UW group (P < 0.05). Also, hospital cost in the UW group was again lower (P < 0.05). In this nonrandomized study, the cold ischemia time was increased but kept close to that of the control group. We conclude that UV solution is an improved donor liver preservation solution on the basis of improved enzyme values, decreased blood usage, shorter hospital stay, and lower hospital charges.

Original languageEnglish (US)
Pages (from-to)1088-1093
Number of pages6
JournalTransplantation
Volume49
Issue number6
StatePublished - 1990
Externally publishedYes

Fingerprint

Cold Ischemia
Liver Transplantation
Transplants
Length of Stay
Hospital Costs
Liver
Enzymes
Hospital Charges
Prothrombin Time
Organ Transplantation
Aspartate Aminotransferases
Bilirubin
Intensive Care Units
Ischemia
Erythrocytes
Tissue Donors
Costs and Cost Analysis
Control Groups
Euro-Collins' solution

ASJC Scopus subject areas

  • Immunology
  • Transplantation

Cite this

Cofer, J. B., Klintmalm, G. B., Howard, T. K., Morris, C. V., Husberg, B. S., Goldstein, R. M., & Gonwa, T. A. (1990). A comparison of UW with Eurocollins preservation solution in liver transplantation. Transplantation, 49(6), 1088-1093.

A comparison of UW with Eurocollins preservation solution in liver transplantation. / Cofer, J. B.; Klintmalm, G. B.; Howard, T. K.; Morris, C. V.; Husberg, B. S.; Goldstein, R. M.; Gonwa, T. A.

In: Transplantation, Vol. 49, No. 6, 1990, p. 1088-1093.

Research output: Contribution to journalArticle

Cofer, JB, Klintmalm, GB, Howard, TK, Morris, CV, Husberg, BS, Goldstein, RM & Gonwa, TA 1990, 'A comparison of UW with Eurocollins preservation solution in liver transplantation', Transplantation, vol. 49, no. 6, pp. 1088-1093.
Cofer JB, Klintmalm GB, Howard TK, Morris CV, Husberg BS, Goldstein RM et al. A comparison of UW with Eurocollins preservation solution in liver transplantation. Transplantation. 1990;49(6):1088-1093.
Cofer, J. B. ; Klintmalm, G. B. ; Howard, T. K. ; Morris, C. V. ; Husberg, B. S. ; Goldstein, R. M. ; Gonwa, T. A. / A comparison of UW with Eurocollins preservation solution in liver transplantation. In: Transplantation. 1990 ; Vol. 49, No. 6. pp. 1088-1093.
@article{d167f0a74c034f29a736614078b470d0,
title = "A comparison of UW with Eurocollins preservation solution in liver transplantation",
abstract = "Fifty consecutive liver transplants were performed using livers perfused with and stored in University of Wisconsin preservation solution. These grafts were compared with the preceding 55 consecutive transplants performed using livers perfused and preserved with Eurocollins solution. The purpose of the study was to determine if organs preserved with UW solution functioned better after transplantation than organs preserved with Eurocollins. Extensive retrospective analysis of prospectively accumulated data included enzyme levels through 30 days, cost and length of hospital stay, blood product usage, and ischemia time. Average age of patients in the UW group was 47.1 years compared with 39.6 years in the EC group (P < 0.05); cold ischemia time was 7.21 hr in the UW group compared with 5.21 in EC (P = 0.0001). Total bilirubin values were significantly lower on days 0-6 and day 14, but not on day 30, in the UW group. Aspartate aminotransferase was significantly lower in the UW group on days 0-1, 3-6, and 14, but not on day 3 or day 30. Prothrombin times were significantly lower in the UW group across all times (day 0-6, 14, and 30). Intraoperative and postoperative use of packed red blood cells and fresh frozen plasma was lower in the UW group (P ≤ .05). Also, total hospital days, intensive care unit days, and hospital cost to the patient were lower in the UW group (P ≤ .05). A second analysis was done comparing only nonemergent transplants from both groups. These results confirmed the initial analysis of a longer cold ischemia time in the UW group, (P < 0.001), and improved enzyme values in the TBR, AST, and PT in the UW group (P < 0.05). Also, hospital cost in the UW group was again lower (P < 0.05). In this nonrandomized study, the cold ischemia time was increased but kept close to that of the control group. We conclude that UV solution is an improved donor liver preservation solution on the basis of improved enzyme values, decreased blood usage, shorter hospital stay, and lower hospital charges.",
author = "Cofer, {J. B.} and Klintmalm, {G. B.} and Howard, {T. K.} and Morris, {C. V.} and Husberg, {B. S.} and Goldstein, {R. M.} and Gonwa, {T. A.}",
year = "1990",
language = "English (US)",
volume = "49",
pages = "1088--1093",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - A comparison of UW with Eurocollins preservation solution in liver transplantation

AU - Cofer, J. B.

AU - Klintmalm, G. B.

AU - Howard, T. K.

AU - Morris, C. V.

AU - Husberg, B. S.

AU - Goldstein, R. M.

AU - Gonwa, T. A.

PY - 1990

Y1 - 1990

N2 - Fifty consecutive liver transplants were performed using livers perfused with and stored in University of Wisconsin preservation solution. These grafts were compared with the preceding 55 consecutive transplants performed using livers perfused and preserved with Eurocollins solution. The purpose of the study was to determine if organs preserved with UW solution functioned better after transplantation than organs preserved with Eurocollins. Extensive retrospective analysis of prospectively accumulated data included enzyme levels through 30 days, cost and length of hospital stay, blood product usage, and ischemia time. Average age of patients in the UW group was 47.1 years compared with 39.6 years in the EC group (P < 0.05); cold ischemia time was 7.21 hr in the UW group compared with 5.21 in EC (P = 0.0001). Total bilirubin values were significantly lower on days 0-6 and day 14, but not on day 30, in the UW group. Aspartate aminotransferase was significantly lower in the UW group on days 0-1, 3-6, and 14, but not on day 3 or day 30. Prothrombin times were significantly lower in the UW group across all times (day 0-6, 14, and 30). Intraoperative and postoperative use of packed red blood cells and fresh frozen plasma was lower in the UW group (P ≤ .05). Also, total hospital days, intensive care unit days, and hospital cost to the patient were lower in the UW group (P ≤ .05). A second analysis was done comparing only nonemergent transplants from both groups. These results confirmed the initial analysis of a longer cold ischemia time in the UW group, (P < 0.001), and improved enzyme values in the TBR, AST, and PT in the UW group (P < 0.05). Also, hospital cost in the UW group was again lower (P < 0.05). In this nonrandomized study, the cold ischemia time was increased but kept close to that of the control group. We conclude that UV solution is an improved donor liver preservation solution on the basis of improved enzyme values, decreased blood usage, shorter hospital stay, and lower hospital charges.

AB - Fifty consecutive liver transplants were performed using livers perfused with and stored in University of Wisconsin preservation solution. These grafts were compared with the preceding 55 consecutive transplants performed using livers perfused and preserved with Eurocollins solution. The purpose of the study was to determine if organs preserved with UW solution functioned better after transplantation than organs preserved with Eurocollins. Extensive retrospective analysis of prospectively accumulated data included enzyme levels through 30 days, cost and length of hospital stay, blood product usage, and ischemia time. Average age of patients in the UW group was 47.1 years compared with 39.6 years in the EC group (P < 0.05); cold ischemia time was 7.21 hr in the UW group compared with 5.21 in EC (P = 0.0001). Total bilirubin values were significantly lower on days 0-6 and day 14, but not on day 30, in the UW group. Aspartate aminotransferase was significantly lower in the UW group on days 0-1, 3-6, and 14, but not on day 3 or day 30. Prothrombin times were significantly lower in the UW group across all times (day 0-6, 14, and 30). Intraoperative and postoperative use of packed red blood cells and fresh frozen plasma was lower in the UW group (P ≤ .05). Also, total hospital days, intensive care unit days, and hospital cost to the patient were lower in the UW group (P ≤ .05). A second analysis was done comparing only nonemergent transplants from both groups. These results confirmed the initial analysis of a longer cold ischemia time in the UW group, (P < 0.001), and improved enzyme values in the TBR, AST, and PT in the UW group (P < 0.05). Also, hospital cost in the UW group was again lower (P < 0.05). In this nonrandomized study, the cold ischemia time was increased but kept close to that of the control group. We conclude that UV solution is an improved donor liver preservation solution on the basis of improved enzyme values, decreased blood usage, shorter hospital stay, and lower hospital charges.

UR - http://www.scopus.com/inward/record.url?scp=0025336632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025336632&partnerID=8YFLogxK

M3 - Article

C2 - 2360252

AN - SCOPUS:0025336632

VL - 49

SP - 1088

EP - 1093

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 6

ER -